Year |
Citation |
Score |
2020 |
Charli JL, Rodríguez-Rodríguez A, Hernández-Ortega K, Cote-Vélez A, Uribe RM, Jaimes-Hoy L, Joseph-Bravo P. The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target? Frontiers in Pharmacology. 11: 640. PMID 32457627 DOI: 10.3389/fphar.2020.00640 |
0.379 |
|
2012 |
Lazcano I, Uribe RM, MartÃnez-Chávez E, Vargas MA, Matziari M, Joseph-Bravo P, Charli JL. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum. The Journal of Pharmacology and Experimental Therapeutics. 342: 222-31. PMID 22532627 DOI: 10.1124/jpet.112.192278 |
0.305 |
|
2008 |
Cruz R, Vargas MA, Uribe RM, Pascual I, Lazcano I, Yiotakis A, Matziari M, Joseph-Bravo P, Charli JL. Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release. Peptides. 29: 1953-64. PMID 18703099 DOI: 10.1016/j.peptides.2008.07.011 |
0.336 |
|
2005 |
Chávez-Gutiérrez L, Bourdais J, Aranda G, Vargas MA, Matta-Camacho E, Ducancel F, Segovia L, Joseph-Bravo P, Charli JL. A truncated isoform of pyroglutamyl aminopeptidase II produced by exon extension has dominant-negative activity. Journal of Neurochemistry. 92: 807-17. PMID 15686482 DOI: 10.1111/j.1471-4159.2004.02916.x |
0.313 |
|
2004 |
Pascual I, Gil-Parrado S, Cisneros M, Joseph-Bravo P, DÃaz J, Possani LD, Charli JL, Chávez M. Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata. in vivo effects in rodent brain. The International Journal of Biochemistry & Cell Biology. 36: 138-52. PMID 14592539 DOI: 10.1016/S1357-2725(03)00175-4 |
0.316 |
|
2002 |
Angel Vargas M, Uribe RM, Cisneros M, Romero F, González S, Joseph-Bravo P, Charli JL. Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis. European Journal of Endocrinology / European Federation of Endocrine Societies. 147: 363-9. PMID 12213674 |
0.313 |
|
1998 |
Pérez-MartÃnez L, Carreón-RodrÃguez A, González-Alzati ME, Morales C, Charli JL, Joseph-Bravo P. Dexamethasone rapidly regulates TRH mRNA levels in hypothalamic cell cultures: interaction with the cAMP pathway. Neuroendocrinology. 68: 345-54. PMID 9822802 DOI: 10.1159/000054383 |
0.308 |
|
1998 |
Charli JL, Vargas MA, Cisneros M, de Gortari P, Baeza MA, Jasso P, Bourdais J, Peréz L, Uribe RM, Joseph-Bravo P. TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II. Neurobiology (Budapest, Hungary). 6: 45-57. PMID 9713831 |
0.38 |
|
1998 |
Vargas MA, Bourdais J, Sanchez S, Uriostegui B, Moreno E, Joseph-Bravo P, Charli JL. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway. Journal of Neuroendocrinology. 10: 199-206. PMID 9576608 DOI: 10.1046/j.1365-2826.1998.00186.x |
0.326 |
|
1998 |
Joseph-Bravo P, Uribe RM, Vargas MA, Pérez-MartÃnez L, Zoeller T, Charli JL. Multifactorial modulation of TRH metabolism. Cellular and Molecular Neurobiology. 18: 231-47. PMID 9535292 DOI: 10.1023/A:1022521020840 |
0.304 |
|
1994 |
Vargas MA, Joseph-Bravo P, Charli JL. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells. Neuroendocrinology. 60: 323-30. PMID 7969791 |
0.365 |
|
1993 |
Brakch N, Boileau G, Simonetti M, Nault C, Joseph-Bravo P, Rholam M, Cohen P. Prosomatostatin processing in Neuro2A cells. Role of beta-turn structure in the vicinity of the Arg-Lys cleavage site. European Journal of Biochemistry / Febs. 216: 39-47. PMID 8103453 DOI: 10.1111/J.1432-1033.1993.Tb18114.X |
0.341 |
|
1990 |
Mendez M, Cruz C, Joseph-Bravo P, Wilk S, Charli JL. Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain. Neuropeptides. 17: 55-62. PMID 1980725 DOI: 10.1016/0143-4179(90)90050-9 |
0.312 |
|
1989 |
Charli JL, Mendez M, Vargas MA, Cisneros M, Assai M, Joseph-Bravo P, Wilk S. Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices. Neuropeptides. 14: 191-6. PMID 2575716 DOI: 10.1016/0143-4179(89)90044-9 |
0.342 |
|
1988 |
Ponce G, Charli JL, Pasten JA, Aceves C, Joseph-Bravo P. Tissue-specific regulation of pyroglutamate aminopeptidase II activity by thyroid hormones. Neuroendocrinology. 48: 211-3. PMID 2906116 |
0.312 |
|
1987 |
Vargas M, Mendez M, Cisneros M, Joseph-Bravo P, Charli JL. Regional distribution of the membrane-bound pyroglutamate amino peptidase-degrading thyrotropin-releasing hormone in rat brain. Neuroscience Letters. 79: 311-4. PMID 2889173 DOI: 10.1016/0304-3940(87)90450-2 |
0.313 |
|
1987 |
Charli JL, Mendez M, Joseph-Bravo P, Wilk S. Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain. Neuropeptides. 9: 373-8. PMID 2886950 DOI: 10.1016/0143-4179(87)90010-2 |
0.337 |
|
1986 |
Torres H, Charli JL, González-Noriega A, Vargas MA, Joseph-Bravo P. Subcellular distribution of the enzymes degrading thyrotropin releasing hormone and metabolites in rat brain. Neurochemistry International. 9: 103-10. PMID 20493107 DOI: 10.1016/0197-0186(86)90038-0 |
0.351 |
|
1979 |
Joseph-Bravo P, Loudes C, Charli JL, Kordon C. Subcellular distribution of brain peptidases degrading luteinizing hormone releasing hormone (LHRH) and thyrotropin releasing hormone (TRH). Brain Research. 166: 321-9. PMID 106928 DOI: 10.1016/0006-8993(79)90217-8 |
0.308 |
|
1979 |
Joseph-Bravo P, Charli JL, Palacios JM, Kordon C. Effect of neurotransmitters on the in vitro release of immunoreactive thyrotropin-releasing hormone from rat mediobasal hypothalamus. Endocrinology. 104: 801-6. PMID 35337 DOI: 10.1210/endo-104-3-801 |
0.326 |
|
1978 |
Charli JL, Joseph-Bravo P, Palacios JM, Kordon C. Histamine-induced release of thyrotropin releasing hormone from hypothalamic slices. European Journal of Pharmacology. 52: 401-3. PMID 103732 DOI: 10.1016/0014-2999(78)90298-4 |
0.305 |
|
Show low-probability matches. |